Cargando…
New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215030/ https://www.ncbi.nlm.nih.gov/pubmed/32420195 http://dx.doi.org/10.21037/tau.2020.03.24 |
| _version_ | 1783532097769570304 |
|---|---|
| author | Lin, Ching-Yu Chuu, Chih-Pin |
| author_facet | Lin, Ching-Yu Chuu, Chih-Pin |
| author_sort | Lin, Ching-Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7215030 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72150302020-05-15 New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer Lin, Ching-Yu Chuu, Chih-Pin Transl Androl Urol Editorial Commentary AME Publishing Company 2020-04 /pmc/articles/PMC7215030/ /pubmed/32420195 http://dx.doi.org/10.21037/tau.2020.03.24 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Lin, Ching-Yu Chuu, Chih-Pin New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title | New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title_full | New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title_fullStr | New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title_full_unstemmed | New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title_short | New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| title_sort | new classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215030/ https://www.ncbi.nlm.nih.gov/pubmed/32420195 http://dx.doi.org/10.21037/tau.2020.03.24 |
| work_keys_str_mv | AT linchingyu newclassificationmayassistthedevelopmentoftargetedtherapiesfortreatmentrefractorycastrationresistantprostatecancer AT chuuchihpin newclassificationmayassistthedevelopmentoftargetedtherapiesfortreatmentrefractorycastrationresistantprostatecancer |